# The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension

> **NCT07359599** · PHASE4 · RECRUITING · sponsor: **Ziekenhuis Oost-Limburg** · enrollment: 306 (estimated)

## Conditions studied

- Pulmonary Hypertension
- Iron Deficiency

## Interventions

- **DRUG:** Ferric Carboxymaltose (FCM)
- **DRUG:** Sodium Chloride (NaCl) 0.9 %

## Key facts

- **NCT ID:** NCT07359599
- **Lead sponsor:** Ziekenhuis Oost-Limburg
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-27
- **Primary completion:** 2028-07
- **Final completion:** 2028-10
- **Target enrollment:** 306 (ESTIMATED)
- **Last updated:** 2026-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07359599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07359599, "The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07359599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*